Vasiyani et al. showed a STING-mediated, NF-kB-induced upregulation of PD-L1 in triple-negative breast cancer cells [50], and Grabosch et al. found PD-L1 upregulation by STING activation in an ovarian cancer mouse model [54]. The gene discussed is STING1; the disease is triple-negative breast carcinoma.